Please try another search
PARIS - Sanofi (NASDAQ:SNY), the global healthcare leader, announced today that François-Xavier Roger will take over as Chief Financial Officer and join its Executive Committee starting April 1,...
PARIS - Sanofi (NASDAQ:SNY), the French multinational pharmaceutical company, reported a solid performance for the fourth quarter of 2023, with a 9.3% growth in sales at constant exchange rates...
PARIS - UBS has maintained its neutral stance on the pharmaceutical company Sanofi (NASDAQ:SNY), setting a target price of €100. This valuation reflects the company's confidence in its drug Dupixent...
By Scott Kanowsky Investing.com -- Shares in Regeneron Pharmaceuticals Inc (NASDAQ:REGN) rose on Friday after the drugmaker posted better-than-expected earnings in the fourth quarter despite a dip in...
By Scott Kanowsky Investing.com -- European equities were broadly lower on Friday, as investors poured over disappointing results from major tech sector players and looked ahead to key U.S. labor...
By Senad Karaahmetovic Amgen (NASDAQ:AMGN) has agreed to acquire Horizon Therapeutics (NASDAQ:HZNP), according to Bloomberg News. Amgen agreed to pay $116.5 for each HZNP share, valuing the deal at...
By Scott Kanowsky Investing.com -- Shares in Sanofi SA (EPA:SASY) rose on Monday after the French drugmaker backed out of its plans to bid for biotech company Horizon Therapeutics PLC...
Are you sure you want to block %USER_NAME%?
By doing so, you and %USER_NAME% will not be able to see any of each other's Investing.com's posts.
%USER_NAME% was successfully added to your Block List
Since you’ve just unblocked this person, you must wait 48 hours before renewing the block.
I feel that this comment is:
Thank You!
Your report has been sent to our moderators for review